Pune-based Emcure Pharmaceuticals has pulled out its proposed red herring prospectus or DRHP with securities market regulator SEBI. Emcure Pharmaceuticals on Wednesday said it has filed a draft red herring prospectus (DRHP) with the Sebi for launching an initial public offer. Pune-based Emcure Pharmaceuticals has filed draft red herring prospectus ( DRHP) with SEBI for initial public offering that includes fresh issue.
|Published (Last):||4 May 2013|
|PDF File Size:||18.91 Mb|
|ePub File Size:||9.57 Mb|
|Price:||Free* [*Free Regsitration Required]|
Here’s how the world is celebrating Christmas. These areas include cardiology, pain and analgesics, HIV, gynecology, nephrology, anti-infective, and vitamins, minerals and nutrients. Rmcure is an infrastructure development company which operates in road, irrigation, real estate and hydro power projects.
NIFTY 50 10, 2. Fri, Dec 20 Emcure becomes the first proposed IPO to be withdrawn after the election results and the fourth since January 1 this year. Sensex finishes year above 36, posts third straight annual gain.
British support-services provider Serco Group Plc. Fortis again pushes back date to complete RHT Health deal; auditor resigns. Fill in your details: The Thomson Reuters Trust Principles.
This follows a deal struck late last year where Blackstone sold its stake to Bain Capital for an undisclosed amount. By Jasleen Kaur Batra. Of these revenues, My Saved Articles Sign in Sign up. E,cure pharmaceutical firm which filed for public offering recently was Intas Pharmaceuticals. Emcure Pharmaceuticals erhp Canadian company and its marketing arm Marcan.
Blackstone has invested Rs crore in Emcure through convertible shares and currently holds a We have not given a thought to a pre-IPO funding round. Blackstone had invested Rs crore in Emcure through convertible shares and held It has subsidiaries in Brazil, DubaiNigeria, Singapore and South Africa and branch offices in Morocco and Russiawhich play an important role in its international operations, the drh said.
In AprilEmcure acquired Heritage Pharmaceuticals, a New Dehp generic pharmaceutical company, which provided it a commercial platform to market and sell its products.
For the nine months ended December 31,Emcure’s revenue from emcue was Rs 1, crore with net profit at Rs Deepti Chaudhary Malvika Joshi. Get instant notifications from Economic Times Allow Not now You can switch off dghp anytime using browser settings. Link Intime India Private Limited is a registrar to the issue. Of these revenues, These areas include cardiology, pain and analgesics, HIV, gynecology, nephrology, anti-infective, and vitamins, minerals and nutrients.
Navy divers re-enter shaft, want water level reduced New Year eve: Pune-based Emcure Pharmaceuticals has pulled out its proposed initial public offer IPO which was to raise around Rs crore besides giving part exit to Blackstone in its maiden investment in India. Warren Buffett has this piece of advice for youngsters and it’s not stocks.
Drag according to your convenience. Emcure operates nine manufacturing facilities, eight of which are located emfure India and one in the United States.
Edited by Joby Puthuparampil Johnson. Interestingly, all the firms which fmcure not to go ahead with public floats are backed by private equity investors. The content may not be copied, broadcast, downloaded and stored in any mediumtransmitted, adapted or changed in any way whatsoever without the prior written permission of Mosaic Media Ventures Private Limited. Emcure was the first private equity investment by a Blackstone-managed fund in Emcute.
Pune-based Emcure Pharmaceuticals has filed draft red herring prospectus DRHP with SEBI for initial public offering that includes fresh issue of upto Rs crore and an offer for sale emcuge upto 25,13, equity share.
For the nine months period ended December The transaction is subject to conditions under contract and law including Foreign Investment Promotion Board approval. This will alert our moderators to take action.
Will the government be able to play It is ranked much higher in the therapeutic areas in which it operates. To see your saved stories, click on link hightlighted in bold.
Book running lead managers to the issue include Bank of America Merrill Lynch. Blackstone has exited now. Your Reason has been Reported to the admin. Thu, Dec 19 Ltd with returns of almost three times.
Emcure Pharmaceuticals files DRHP for IPO – The Economic Times
Emcure is ranked as the 14th-largest pharmaceutical company in India in terms of market share based on the domestic sales of pharmaceutical products. Reliance to buy majority stake in renewable energy services firm Kanoda. Leave Your Comment s.